Centre Hospitalier de PAU
17
2
3
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
11.8%
2 terminated/withdrawn out of 17 trials
81.8%
-4.7% vs industry average
12%
2 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
3-hour Versus 12-hour Double-balloon Catheter for Labor Induction
Role: lead
A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort
Role: lead
Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment
Role: lead
Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
Role: lead
Determinants of Malignant Hypertension Onset and Related Target Organ Damages: the HAMA Biobank
Role: lead
A Procalcitonin-based Algorithm in Adhesion-related Small Bowel Obstruction
Role: collaborator
Evaluation of Hypnosis Practice During a Semi-invasive and Painful Medical Examination in Neurology: the Electromyogram
Role: lead
Evaluation of Rapid Emergency Echography for Acute Dyspnoea
Role: collaborator
Interrupters of VAscular daMAge in Malignant Hypertension
Role: lead
Feasibility of Immunotherapy Plus Chemotherapy Administration to Patients With Bronchial Cancer in a Hospital-at- Home Setting
Role: lead
Prevalence of Primary Aldosteronism Among Hypertensive Patients With Atrial Arythmia
Role: lead
SCREENING FOR THE IMPLANTATION OF A SUBCUTANEOUS IMPLANTABLE AUTOMATIC DEFIBRILLATOR
Role: lead
S-ICD French Cohort Study (HONEST)
Role: collaborator
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection
Role: lead
OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA
Role: collaborator
Intrathecal Rituximab in Progressive Multiple Sclerosis
Role: lead
Anticoagulant Treatments and Percutaneous Coronary Angioplasty
Role: lead
All 17 trials loaded